Table 4.
Measure | Definition | Studies with requisite measure, n (%)a | Study citations |
Explicit MU motive |
|
18 (24) | [7,18,30,32,37,42,45,55-65] |
Mention of MU |
|
40 (53) | [6,8-10,33,36,38-40,43,44,47,50,53,54,66-90] |
Access |
|
45 (59) | [6,9,18,30,32,33,36-38,40,42-45,50,51,53-56,58,60-66,69,71,72,80-82,85,87-96] |
Send |
|
45 (59) | [8-10,18,30,32,35,39,40,42-44,50,51,54-60,62,63,65-67,70-73,75-78,85-88,91,94-99] |
View-download-transmit (VDT) |
|
9 (12) | [36,42,56,60,61,65,72,81,96] |
MU-2 |
|
6 (8) | [42,56,60,65,72,96] |
aPercentages exceed 100% total because studies could meet more than one criterion, and MU-2 represents studies that met all three conditions (access, send, and VDT) that together entail the full requirements of Centers for Medicare & Medicaid Services MU stage 2.